Attached files
| file | filename |
|---|---|
| 10-K/A - China Botanic Pharmaceutical | v167850_10ka.htm |
| EX-23.1 - China Botanic Pharmaceutical | v167850_ex23-1.htm |
| EX-31.2 - China Botanic Pharmaceutical | v167850_ex31-2.htm |
| EX-31.1 - China Botanic Pharmaceutical | v167850_ex31-1.htm |
| EX-32.2 - China Botanic Pharmaceutical | v167850_ex32-2.htm |
EXHIBIT
32.1
CERTIFICATION
PURSUANT TO
18
U.S.C. SECTION 1350,
AS
ADOPTED PURSUANT TO
SECTION
906 OF THE SARBANES-OXLEY ACT OF 2002
In
connection with the Annual Report of Renhuang Pharmaceuticals, Inc. (the
“Company”) on Form 10-K/A for the period ending October 31, 2008, as filed with
the Securities and Exchange Commission on the date hereof (the “Report”), I,
Shaoming Li, Chief Executive Officer of the Company, hereby certify,
pursuant to 18 U.S.C. § 1350, as adopted pursuant to § 906 of the Sarbanes-Oxley
Act of 2002, that, to the best of my knowledge, based upon a review of the
Report:
(1) The
Report fully complies with the requirements of Section 13(a) or 15(d) of the
Securities Exchange Act of 1934; and
(2) The
information contained in the Report fairly presents, in all material respects,
the financial condition and results of operation of the Company.
|
/s/ Shaoming
Li
|
|
Shaoming
Li
|
|
Chairman
and Chief Executive Officer
(Principle
Executive Officer)
|
Dated:
December 8, 2009